{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:28:11Z","timestamp":1793618891297,"version":"4.5.0"},"reference-count":16,"publisher":"Walter de Gruyter GmbH","issue":"12","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2026-0815_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>External quality assessment (EQA) is essential for ensuring reliable biochemical genetic testing. This study evaluated long-term performance trends in ERNDIM quantitative EQA schemes, including special assays in serum (SAS), special assays in urine (SAU), purines and pyrimidines in urine (PPU), quantitative organic acids in urine (QTOU), quantitative amino acids in serum (QTAS), acylcarnitines in serum (ACS), and special assays in dried blood spots (SADB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-0815_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Longitudinal trends in between- and within-laboratory coefficient of variation (CV) and their ratios as indicators of harmonisation were evaluated using ERNDIM EQA annual report data from 2000 to\u00a02024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-0815_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Means of between- and within-laboratory CVs differed substantially across schemes. In 2024, between- respective within-laboratory CVs (%) were: QTAS 10;6, SAS 12;7, SAU 14;7, PPU 14;8, ACS 25;10; SABD 26;10, and QTOU 36;17. Marked variability was also observed across individual analytes, particularly for low-concentration metabolites, compounds with specific functional groups, and those analysed without isotopically labelled internal standards. Improvements in CVs were mainly seen in the early years of EQA scheme implementation. No longitudinal trend was observed for QTAS, which consistently showed the best performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-0815_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The marked variation in performance between schemes and analytes may be linked to differences in analytical methodology, analyte properties, availability of commercial reference materials, sample matrix, and experience. Overall, ERNDIM quantitative schemes effectively monitor performance, support harmonisation, and provide educational feedback.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2026-0815","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:59:24Z","timestamp":1785229164000},"page":"2843-2853","source":"Crossref","is-referenced-by-count":0,"title":["Improving the performance of biochemical genetic testing through external quality assessment"],"prefix":"10.1515","volume":"64","author":[{"given":"Katrin","family":"Freiburghaus","sequence":"first","affiliation":[{"name":"University Institute of Clinical Chemistry , Inselspital, Bern University Hospital, University of Bern , Bern , Switzerland"},{"name":"Graduate School for Health Sciences , University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cas","family":"Weykamp","sequence":"additional","affiliation":[{"name":"MCA Laboratory , Queen Beatrix Hospital , Winterswijk , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Carling","sequence":"additional","affiliation":[{"name":"Biochemical Sciences , Synnovis Analytics , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ruiz-Sala","sequence":"additional","affiliation":[{"name":"Molecular Disease Diagnostic Center (CEDEM) , Autonomous University of Madrid (UAM), CIBERER, IdiPAz , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Artuch","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Department , Institut de Recerca Sant Joan de Deu and CIBERER , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clothilde","family":"Roux","sequence":"additional","affiliation":[{"name":"Clinical Chemistry Laboratory , Lausanne University Hospital (CHUV) , Lausanne , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rgen","family":"Bierau","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Center for Lysosomal and Metabolic Diseases , Erasmus University Medical Center , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier","family":"Schoeman","sequence":"additional","affiliation":[{"name":"MCA Laboratory , Queen Beatrix Hospital , Winterswijk , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ruijter","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Center for Lysosomal and Metabolic Diseases , Erasmus University Medical Center , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Mathis","sequence":"additional","affiliation":[{"name":"University Institute of Clinical Chemistry , Inselspital, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"2026110211032908344_j_cclm-2026-0815_ref_001","doi-asserted-by":"crossref","unstructured":"Sciacovelli, L, Secchiero, S, Zardo, L, Zaninotto, M, Plebani, M. External quality assessment: an effective tool for clinical governance in laboratory medicine. Clin Chem Lab Med 2006;44:740\u20139. https:\/\/doi.org\/10.1515\/cclm.2006.133.","DOI":"10.1515\/CCLM.2006.133"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_002","doi-asserted-by":"crossref","unstructured":"Oglesbee, D, Cowan, TM, Pasquali, M, Wood, TC, Weck, KE, Long, T, et al.. CAP\/ACMG proficiency testing for biochemical genetics laboratories: a summary of performance. Genet Med 2018;20:83\u201390. https:\/\/doi.org\/10.1038\/gim.2017.61.","DOI":"10.1038\/gim.2017.61"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_003","doi-asserted-by":"crossref","unstructured":"Fowler, B, Burlina, A, Kozich, V, Vianey-Saban, C. Quality of analytical performance in inherited metabolic disorders: the role of ERNDIM. J\u00a0Inherit Metab Dis 2008;31:680\u20139. https:\/\/doi.org\/10.1007\/s10545-008-1025-4.","DOI":"10.1007\/s10545-008-1025-4"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_004","doi-asserted-by":"crossref","unstructured":"Horwitz, W, Albert, R. The Horwitz ratio (HorRat): a useful index of method performance with respect to precision. J\u00a0AOAC Int 2006;89:1095\u2013109. https:\/\/doi.org\/10.1093\/jaoac\/89.4.1095.","DOI":"10.1093\/jaoac\/89.4.1095"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_005","doi-asserted-by":"crossref","unstructured":"Cobbaert, C, Weykamp, C, Franck, P, de Jonge, R, Kuypers, A, Steigstra, H, et al.. Systematic monitoring of standardization and harmonization status with commutable EQA-samples-five year experience from the Netherlands. Clin Chim Acta 2012;414:234\u201340. https:\/\/doi.org\/10.1016\/j.cca.2012.09.027.","DOI":"10.1016\/j.cca.2012.09.027"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_006","doi-asserted-by":"crossref","unstructured":"Thompson, M, Wood, R. Roger. The \u2018Horwitz ratio\u2019\u00a0\u2013\u00a0a study of the ratio between reproducibility and repeatability precisions in the analysis of foodstuffs. Anal Methods 2015;7:375\u20139. https:\/\/doi.org\/10.1039\/c4ay02020k.","DOI":"10.1039\/C4AY02020K"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_007","doi-asserted-by":"crossref","unstructured":"Sala, PR, Ruijter, G, Acquaviva, C, Chabli, A, de Sain-van der Velden, MG, Garcia-Villoria, J, et al.. Pilot experience with an external quality assurance scheme for acylcarnitines in plasma\/serum. JIMD Rep 2016;30:23\u201331.","DOI":"10.1007\/8904_2016_533"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_008","doi-asserted-by":"crossref","unstructured":"Mathis, D, Croft, J, Chrastina, P, Fowler, B, Vianey-Saban, C, Ruijter, GJG. The role of ERNDIM diagnostic proficiency schemes in improving the quality of diagnostic testing for inherited metabolic diseases. J\u00a0Inherit Metab Dis 2022;45:926\u201336. https:\/\/doi.org\/10.1002\/jimd.12523.","DOI":"10.1002\/jimd.12523"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_009","doi-asserted-by":"crossref","unstructured":"Peters, V, Bonham, JR, Hoffmann, GF, Scott, C, Langhans, CD. Qualitative urinary organic acid analysis: 10\u00a0years of quality assurance. J\u00a0Inherit Metab Dis 2016;39:683\u20137. https:\/\/doi.org\/10.1007\/s10545-016-9941-1.","DOI":"10.1007\/s10545-016-9941-1"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_010","doi-asserted-by":"crossref","unstructured":"Peters, V, Garbade, SF, Langhans, CD, Hoffmann, GF, Pollitt, RJ, Downing, M, et al.. Qualitative urinary organic acid analysis: methodological approaches and performance. J\u00a0Inherit Metab Dis 2008;31:690\u20136. https:\/\/doi.org\/10.1007\/s10545-008-0986-7.","DOI":"10.1007\/s10545-008-0986-7"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_011","doi-asserted-by":"crossref","unstructured":"Moat, SJ, George, RS, Carling, RS. Use of dried blood spot specimens to monitor patients with inherited metabolic disorders. Int J Neonatal Screen 2020;6:26. https:\/\/doi.org\/10.3390\/ijns6020026.","DOI":"10.3390\/ijns6020026"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_012","doi-asserted-by":"crossref","unstructured":"Mathis, D, Beese, K, Ruegg, C, Plecko, B, Hersberger, M. LC-MS\/MS method for the differential diagnosis of treatable early onset inherited metabolic epilepsies. J\u00a0Inherit Metab Dis 2020;43:1102\u201311. https:\/\/doi.org\/10.1002\/jimd.12244.","DOI":"10.1002\/jimd.12244"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_013","doi-asserted-by":"crossref","unstructured":"Mathis, D, Prost, JC, Maeder, G, Arackal, L, Zhang, H, Kurth, S, et al.. Specific GAG ratios in the diagnosis of mucopolysaccharidoses. JIMD Rep 2024;65:116\u201323. https:\/\/doi.org\/10.1002\/jmd2.12412.","DOI":"10.1002\/jmd2.12412"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_014","doi-asserted-by":"crossref","unstructured":"Berchier, K, Nyffeler, C, Bruce, S, Roux, C, Nuoffer, JM, Gautschi, M, et al.. Pre-analytical considerations in the simultaneous quantification of ketone bodies, lactate, pyruvate and TCA cycle intermediates. Clin Biochem 2026;141:111056. https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111056.","DOI":"10.1016\/j.clinbiochem.2025.111056"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_015","doi-asserted-by":"crossref","unstructured":"Carling, RS, Witek, K, Emmett, EC, Gallagher, C, Moat, SJ. Urine organic acid metabolomic profiling by gas chromatography mass spectrometry: assessment of solvent extract evaporation parameters on the recovery of key diagnostic metabolites. Clin Chim Acta 2025;565:120015. https:\/\/doi.org\/10.1016\/j.cca.2024.120015.","DOI":"10.1016\/j.cca.2024.120015"},{"key":"2026110211032908344_j_cclm-2026-0815_ref_016","doi-asserted-by":"crossref","unstructured":"Whyte, E, Carling, R, Cowen, S, Sears, P, Hopley, C. Development of an SI traceable value assigned amino acid matrix-matched material to underpin European external quality assessment. Anal Bioanal Chem 2025;417:2669\u201378. https:\/\/doi.org\/10.1007\/s00216-025-05793-4.","DOI":"10.1007\/s00216-025-05793-4"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0815\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0815\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:05:41Z","timestamp":1793617541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-0815\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,11,25]]}},"alternative-id":["10.1515\/cclm-2026-0815"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-0815","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}